These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 28673854)

  • 1. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoantibiotics: a new paradigm for the treatment of surgical infection.
    Fernandez-Moure JS; Evangelopoulos M; Colvill K; Van Eps JL; Tasciotti E
    Nanomedicine (Lond); 2017 Jun; 12(11):1319-1334. PubMed ID: 28520517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
    Alabresm A; Chandler SL; Benicewicz BC; Decho AW
    Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
    Qumsani AT
    Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combatting antibiotic-resistant bacteria using nanomaterials.
    Gupta A; Mumtaz S; Li CH; Hussain I; Rotello VM
    Chem Soc Rev; 2019 Jan; 48(2):415-427. PubMed ID: 30462112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.
    Van Giau V; An SSA; Hulme J
    Drug Des Devel Ther; 2019; 13():327-343. PubMed ID: 30705582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 13. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antibacterial nanoparticles for pathogenic bacteria.
    Lai HZ; Chen WY; Wu CY; Chen YC
    ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium complexes/polypeptide self-assembled nanoparticles for identification of bacterial infection and targeted antibacterial research.
    Huang N; Chen X; Zhu X; Xu M; Liu J
    Biomaterials; 2017 Oct; 141():296-313. PubMed ID: 28709020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
    Benoit DS; Koo H
    Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
    [No Abstract]   [Full Text] [Related]  

  • 20. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.